Edition:
India

People: Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

46.17USD
8:37pm IST
Change (% chg)

$0.56 (+1.23%)
Prev Close
$45.61
Open
$45.86
Day's High
$46.21
Day's Low
$45.01
Volume
15,786
Avg. Vol
170,707
52-wk High
$51.49
52-wk Low
$31.98

Lind, Kevin 

Mr. Kevin R. Lind is Chief Financial Officer, Executive Vice President of the Company. He has served as our Executive Vice President and Chief Financial Officer since June 2016. Previously, Mr. Lind was a Principal focused on healthcare at TPG Special Situations Partners, a global investment firm, from January 2009 to June 2016. Mr. Lind was a member of the TPG Pharma Partners effort at TPG-Axon, a global investment firm, from 2006 to 2008. He served in various capacities as a healthcare investment banker at Lehman Brothers, Inc., a former global financial services firm, from 1998 to 2002 and 2004 to 2006. Mr. Lind received a B.S. from Stanford University in Biological Sciences and an M.B.A. from UCLA Anderson School of Management.

Basic Compensation

Total Annual Compensation, USD 697,882
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 868,083
Fiscal Year Total, USD 1,565,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tina Nova

193,840

Amit Munshi

2,915,940

Kevin Lind

1,565,960

Steven Spector

1,599,320

Vincent Aurentz

1,612,650

Preston Klassen

1,787,280
As Of  31 Dec 2017